GenNext Biotech Revenue and Competitors
Estimated Revenue & Valuation
- GenNext Biotech's estimated annual revenue is currently $310k per year.
- GenNext Biotech's estimated revenue per employee is $155,000
Employee Data
- GenNext Biotech has 2 Employees.
- GenNext Biotech grew their employee count by -60% last year.
GenNext Biotech's People
Name | Title | Email/Phone |
---|---|---|
1 | Territory Manager | Reveal Email/Phone |
GenNext Biotech Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $9.3M | 60 | 20% | N/A | N/A |
#2 | $9.1M | 59 | -34% | N/A | N/A |
#3 | $1.1M | 7 | 17% | N/A | N/A |
#4 | $0.3M | 2 | -93% | N/A | N/A |
#5 | $4.3M | 28 | 4% | N/A | N/A |
#6 | $1.4M | 9 | 50% | N/A | N/A |
#7 | $6M | 39 | 3% | N/A | N/A |
#8 | $15.8M | 102 | 7% | N/A | N/A |
#9 | $18M | 116 | 0% | $20.5M | N/A |
#10 | $34.1M | 176 | 13% | $39.1M | N/A |
What Is GenNext Biotech?
Harvested from nature's richest soils, GenNext M3D™ Technology allows your plants to take on the attributes of the world's most resilient natural grasses. We identify and extract over 3,000 specific proteins, hormones, and enzymes – the good stuff – from select microbes found in natural prairie grasses, corn composts, and various turfgrass species. Each of these microbes has a specific function, whether to decompose dead matter to form organic material, to free “tied-up†nutrients from the soil and from dead matter, or to release agents to kill and prevent certain pathogens. No matter their role – these microbes make up the core of our M3D™ Technology, possessing innate resilience and growth characteristics. Together, they trigger the vital reactions needed for plant growth and soil respiration.
keywords:N/AN/A
Total Funding
2
Number of Employees
$310k
Revenue (est)
-60%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.1M | 2 | -33% | N/A |
#2 | $0.1M | 2 | -33% | N/A |
#3 | $0.2M | 3 | -25% | N/A |
#4 | $0.2M | 3 | N/A | N/A |
#5 | $0.2M | 3 | -25% | N/A |